Cite
FRI-306 Insulin resistance in metabolic associated steatotic liver disease and its association with liver-related outcomes: a retrospective study and a nationwide, population-based study.
MLA
Kang, Yeo Wool, et al. “FRI-306 Insulin Resistance in Metabolic Associated Steatotic Liver Disease and Its Association with Liver-Related Outcomes: A Retrospective Study and a Nationwide, Population-Based Study.” Journal of Hepatology, vol. 80, June 2024, p. S501. EBSCOhost, https://doi.org/10.1016/S0168-8278(24)01524-1.
APA
Kang, Y. W., Baek, Y.-H., Moon, S. Y., & Son, M. (2024). FRI-306 Insulin resistance in metabolic associated steatotic liver disease and its association with liver-related outcomes: a retrospective study and a nationwide, population-based study. Journal of Hepatology, 80, S501. https://doi.org/10.1016/S0168-8278(24)01524-1
Chicago
Kang, Yeo Wool, Yang-Hyun Baek, Sang Yi Moon, and MinKook Son. 2024. “FRI-306 Insulin Resistance in Metabolic Associated Steatotic Liver Disease and Its Association with Liver-Related Outcomes: A Retrospective Study and a Nationwide, Population-Based Study.” Journal of Hepatology 80 (June): S501. doi:10.1016/S0168-8278(24)01524-1.